
pmid: 35104331
interstitial lung disease, Lung Diseases, autoantibodies, Arthritis, immunomodulation, cross-specialty collaboration, United Kingdom, Interstitial/therapy, Arthritis, Rheumatoid, Rheumatology, Rheumatoid, multi-disciplinary team (MDT), Humans, Lung Diseases, Interstitial/therapy, Rheumatologists, Lung Diseases, Interstitial
interstitial lung disease, Lung Diseases, autoantibodies, Arthritis, immunomodulation, cross-specialty collaboration, United Kingdom, Interstitial/therapy, Arthritis, Rheumatoid, Rheumatology, Rheumatoid, multi-disciplinary team (MDT), Humans, Lung Diseases, Interstitial/therapy, Rheumatologists, Lung Diseases, Interstitial
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
